Evolent Health (EVH) PT Raised to $31 at Oppenheimer Following Market Analysis
Tweet Send to a Friend
Oppenheimer raised its price target on Evolent Health (NYSE: EVH) to $31.00 (from $22.00) while maintaining a Outperform rating following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
